Currently, the most advanced insulin therapy systems in paediatric patients with type 1 diabetes mellitus (T1DM) are the Advanced Hybrid Closed Loop systems (AHCL) that automatically regulate insulin delivery according to glycaemic values, integrated with real-time continuous glucose monitoring (rt-CGM). The gene discussed is INS; the disease is diabetes mellitus.